Morrison & Foerster LLP advised Ally Bridge Group on the deal.

Morrison & Foerster LLP advised Ally Bridge Group on the deal.

Ally Bridge Group, a global life-science dedicated investment group, announced an equity financing totaling US$108 million in medical device company Mainstay Medical Holdings plc.

Ally Bridge Group (HK) Limited provides wealth management services. The Company mainly offers portfolio management, financial planning, and investment advisory services. Ally Bridge Group (HK) serves customers in Hong Kong.

Mainstay Medical Holdings plc manufactures medical devices designed to treat people with chronic low back pain. The Company has operations in Ireland, Australia and the United States.

The cross-border, cross-practice MoFo team for Mainstay Medical comprised of corporate partner and co-head of Asia private equity Thomas Chou (Picture) in Hong Kong, corporate associate James Lee, technology transactions partner Aaron Rubin and associate Alex Siegel in San Francisco, finance partner Yemi Tépé and associate Charlyn Lim in Singapore, Dom Bozzetti in New York and associate Yuan Xia in San Francisco for equity compensation issues, patent partner Janet Xiao in Palo Alto, CFIUS of counsel Panagiotis Bayz and associate Jonathan Babcock in Washington D.C.

Involved fees earner: Jonathan Babcock – Morrison Foerster; Panagiotis Bayz – Morrison Foerster; Domnick Bozzetti – Morrison Foerster; Thomas Chou – Morrison Foerster; James Lee – Morrison Foerster; Charlyn Lim – Morrison Foerster; Aaron Rubin – Morrison Foerster; Alex Siegel – Morrison Foerster; Yemi Tépé – Morrison Foerster; Yuan Xia – Morrison Foerster; Janet Xiao – Morrison Foerster;

Law Firms: Morrison Foerster;

Clients: Ally Bridge Group;

Author: Sonia Carcano